Delivery Order SPE2DB22D3004-SPE2DB24FRC79
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.42 fixed-price contract is for the delivery of Toviaz ER 8 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of pharmaceutical products, including the medication Toviaz ER 8 mg Tablet, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Ceiling Value of $1,973.53 and has a Firm Fixed Price pricing type. The ultimate completion date is April 28, 2023. This contract award is not designated with a set-aside....
This federal contract award, with ID SPE2DB22D2218|SPE2DB25FR2HY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Toviaz ER 8 mg tablets. The contract has a firm fixed price, a ceiling value of $1,203.84, and an ultimate completion date of April 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,014.82, is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price, delivery order contract. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,724.21, is for the delivery of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance extending through May 28, 2025. This award is not associated with a set-aside designation,...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FEXD6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.11 firm-fixed-price delivery order is for the supply of 4564910533 TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024 and was awarded on June 14, 2024. AmerisourceBergen, a for-profit organization,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,522.18 and is a firm-fixed-price (FFP) delivery order with a performance period through June 13, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies to support federal medical programs, particularly those...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the supply of Tizanidine HCl 4 mg capsules. The contract has a ceiling value of $1,126.54 and a period of performance through May 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, with a ceiling value of $10,396.92. The contract is a firm fixed-price delivery order for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, hormones, and antibiotics. The contract has no set-aside designation, indicating open...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of pharmaceutical products, including a tablet medication. The contract has a ceiling value of $13,929.10 and a completion date of January 13, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...